Physician profile
Gregory Mitchell
NPI 1861498024
$9,478.62
in general payments reported to CMS, 2019-2025
15 companies · $1,174 in 2025
The $1,174 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $90.15 · 2021: $74.58 · 2022: $181 · 2023: $4,650 · 2024: $3,308 · 2025: $1,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $3,027 · Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $3,026.95 |
| Food and Beverage | $605.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,621.57 | 2023-2025 | |
| Abbvie INC. | $274.21 | 2021-2025 | |
| Smith+Nephew, INC. | $170.33 | 2024-2025 | Pico 7 |
| Astellas Pharma US INC | $72.55 | 2023-2025 | Veozah |
| Axonics, INC. | $71.88 | 2020-2022 | |
| Applied Medical Resources Corporation | $46.38 | 2023 | Gelpoint V-Path |
| Roche Diagnostics Corporation | $40.67 | 2020 | |
| Pfizer INC. | $33.85 | 2024 | |
| Biogen, INC. | $29.12 | 2024 | |
| Allergan, INC. | $24.49 | 2020 | |
| Exeltis, USA INC. | $23.64 | 2025 | Slynd |
| Millicent US INC | $22.73 | 2025 | Intrarosa, Femlyv |
| Hologic Sales and Service, LLC | $21.12 | 2024 | Omni Hysteroscope |
| Shield Therapeutics INC | $17.27 | 2023 | Accrufer |
| Organon LLC | $8.81 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.